The Russian research company, located in Novosibirsk, creates wound healing preparation of new generation in the form of a spray.
The wound healing agent has packaged in 15–50 ml vials, allowing to apply the contents of the vial to the surface of the wound. The capacity of the bottle, the material from which it is made, can be changed by request of the partner.
The company was established in 2002 as a biotechnological enterprise whose activity is aimed at solving specific problems in the field of microbiology, virology and biochemistry.
The use of oxidized dextran as an active ingredient in the preparation is the main advantage. Because of using it the drug accelerates the regeneration of tissues, provides a higher rate of wound healing with a fewer amount of complications.
The amount of soft tissue damage associated with ruptures, injuries, burns is enormous and cannot be statistically evaluated. Preparations for accelerating wound healing presented on the market often do not solve the problem, they do not clean the wound surface from necrotic tissues, and it is the cause of possible complications. For example, in abdominal surgery, complications associated with wound suppuration ranges from 6-12%.
• The product of the company combines active wound healing substance with anesthetic.
• Preparation has a higher rate of wound healing with a fewer amount of complications.
• The effectiveness of preparation is 2-3 times higher than the analogs.
The partners from health sectors are looking for distribution services agreements. In the framework of distribution services agreement the partner orders the company’s products or raw materials, the company supplies products or raw materials. Since the products have a medical effect, with the partner the company plans to certificate it (joint payment of the company and the partner) or the company can supply raw materials for the subsequent packaging and sale of finished products by the partner. Now the company sale it as hygienic skin care product that promotes wound healing. The result of cooperation: the sale of the drug on the international market.